5.38 - 5.60
4.95 - 8.28
2.3K / 2.4K (Avg.)
-279.00 | -0.02
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
-2.12%
Both firms have declining sales. Martin Whitman would suspect an industry slump or new disruptive entrants.
202.67%
Gross profit growth above 1.5x STERV.HE's 110.10%. David Dodd would confirm if the company's business model is superior in terms of production costs or pricing.
269.03%
Positive EBIT growth while STERV.HE is negative. John Neff might see a substantial edge in operational management.
269.03%
Positive operating income growth while STERV.HE is negative. John Neff might view this as a competitive edge in operations.
418.89%
Net income growth above 1.5x STERV.HE's 100.00%. David Dodd would check if a unique moat or cost structure secures superior bottom-line gains.
414.96%
EPS growth above 1.5x STERV.HE's 97.13%. David Dodd would review if superior product economics or effective buybacks drive the outperformance.
414.96%
Diluted EPS growth above 1.5x STERV.HE's 97.13%. David Dodd would see if there's a robust moat protecting these shareholder gains.
1.11%
Share change of 1.11% while STERV.HE is at zero. Bruce Berkowitz would see if slight buybacks (or dilution) matter in the bigger picture.
1.11%
Diluted share count expanding well above STERV.HE's 0.12%. Michael Burry would fear significant dilution to existing owners' stakes.
-100.00%
Both companies cut dividends. Martin Whitman would look for a common factor, such as cyclical downturn or liquidity constraints.
153.49%
Positive OCF growth while STERV.HE is negative. John Neff would see this as a clear operational advantage vs. the competitor.
-74.15%
Both companies show negative FCF growth. Martin Whitman would consider an industry-wide capital spending surge or margin compression.
-3.36%
Both companies have negative long-term revenue/share growth. Martin Whitman would question if the entire market or product set is shrinking.
1.08%
Positive 5Y CAGR while STERV.HE is negative. John Neff might see an underappreciated edge for the firm vs. the competitor.
-4.19%
Both firms have negative 3Y CAGR. Martin Whitman would wonder if the entire market segment is in short-term retreat.
-91.08%
Negative 10Y OCF/share CAGR while STERV.HE stands at 17.55%. Joel Greenblatt would scrutinize managerial effectiveness and product competitiveness.
-89.59%
Both show negative mid-term OCF/share growth. Martin Whitman might suspect a challenged environment or large capital demands for both.
-92.29%
Both face negative short-term OCF/share growth. Martin Whitman would suspect macro or cyclical issues hitting them both.
37.31%
Positive 10Y CAGR while STERV.HE is negative. John Neff might see a substantial advantage in bottom-line trajectory.
-12.49%
Negative 5Y net income/share CAGR while STERV.HE is 25.71%. Joel Greenblatt would see fundamental missteps limiting profitability vs. the competitor.
-64.04%
Both companies show negative 3Y net income/share growth. Martin Whitman suspects macro or sector-specific headwinds in the short run.
108.37%
10Y equity/share CAGR in line with STERV.HE's 106.54%. Walter Schloss might see both benefiting from stable profitability and moderate payout ratios over the decade.
36.57%
5Y equity/share CAGR at 50-75% of STERV.HE's 57.45%. Martin Whitman would question a shortfall in capital accumulation vs. the competitor.
7.77%
3Y equity/share CAGR at 50-75% of STERV.HE's 10.80%. Martin Whitman sees a short-term lag in net worth creation vs. the competitor.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
-100.00%
Both reduce receivables yoy. Martin Whitman suspects a shift in the entire niche’s credit approach or softer demand.
3.40%
Inventory shrinking or stable vs. STERV.HE's 14.13%. David Dodd confirms the company’s supply-chain is more efficient if sales are unaffected.
2.00%
Asset growth above 1.5x STERV.HE's 0.30%. David Dodd checks if M&A or new capacity expansions are value-accretive vs. competitor's approach.
1.73%
BV/share growth above 1.5x STERV.HE's 0.80%. David Dodd confirms if consistent profit retention or fewer write-downs yield faster equity creation.
-80.84%
Both reduce debt yoy. Martin Whitman sees a broader sector shift to safer balance sheets or less growth impetus.
No Data
No Data available this quarter, please select a different quarter.
-100.00%
Both reduce SG&A yoy. Martin Whitman sees a cost war or cyclical slowdown forcing overhead cuts.